SCHEMBL3198744

SCHEMBL3198744

CC(=O)c1ccc([S+](c2ccc(C(C)=O)cc2)c2ccc(C(C)=O)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.54
RAB9A P51151 5/20 0.54
HPGD P15428 4/20 0.54
LMNA P02545 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
KMT2A Q03164 2/20 0.54
SMN1; SMN2 Q16637 3/20 0.52
HSD17B1 P14061 1/20 0.52
MAPK1 P28482 3/20 0.48
NOS3 P29474 2/20 0.48
NOS1 P29475 2/20 0.48
NPC1 O15118 4/20 0.46
ALDH1A1 P00352 1/20 0.46
STAT3 P40763 1/20 0.46
STAT1 P42224 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GAA P10253 1/20 0.45
TAAR1 Q96RJ0 1/20 0.43
STS P08842 1/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3215658 0.91 MAPT (0.61) MAPTRAB9AHPGDLMNAL3MBTL1
SCHEMBL3205192 0.91 MAPT (0.61) MAPTRAB9AHPGDLMNAL3MBTL1
SCHEMBL570189 0.87 HPGD (0.79) MAPTRAB9AHPGDLMNAL3MBTL1
SCHEMBL9888772 0.87 HPGD (0.79) MAPTRAB9AHPGDLMNAL3MBTL1
SCHEMBL9888809 0.87 HPGD (0.79) MAPTRAB9AHPGDLMNAL3MBTL1
SCHEMBL50646 0.85 MAPT (0.68) MAPTRAB9AHPGDLMNAL3MBTL1
SCHEMBL29482282 0.85 MAPT (0.53) MAPTRAB9AHPGDLMNAKMT2A
SCHEMBL1061558 0.83 MAPT (0.59) MAPTRAB9AHPGDLMNAL3MBTL1
SCHEMBL1576901 0.82 MAPK1 (0.48) MAPTRAB9AHPGDLMNAL3MBTL1
SCHEMBL9888798 0.82 HPGD (0.70) MAPTRAB9AHPGDLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180011401-A1 SULFONIC ACID DERIVATIVE, PHOTOACID GENERATOR USING SAME, RESIST COMPOSITION, AND DEVICE MANUFACTURING METHOD TOYO GOSEI CO., LTD. (JP) 2018-01-11 US disclosed
US-20130130175-A1 Compound for Photoacid Generator, Resist Composition Using the Same, and Pattern-Forming Method CENTRAL GLASS COMPANY, LIMITED (JP) 2013-05-23 US disclosed
US-8435717-B2 Compound for photoacid generator, resist composition using the same, and pattern-forming method CENTRAL GLASS COMPANY, LIMITED (JP) 2013-05-07 US disclosed
US-20100035185-A1 Compound for Photoacid Generator, Resist Composition Using the Same, and Pattern-Forming Method CENTRAL GLASS COMPANY, LTD. (JP) 2010-02-11 US disclosed
US-7414148-B2 Process for producing alkoxycarbonylfluoroalkanesulfonates CENTRAL GLASS COMPANY LIMITED (JP) 2008-08-19 US disclosed
US-20080108846-A1 PROCESS FOR PRODUCING ALKOXYCARBONYLFLUOROALKANESULFONATES CENTRAL GLASS COMPANY, LIMITED (JP) 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180011401-A1 SULFONIC ACID DERIVATIVE, PHOTOACID GENERATOR USING SAME, RESIST COMPOSITION, AND DEVICE MANUFACTURING METHOD ASIC1, ASIC3, CRY1 MAPT 4292/4885RAB9A 2384/4885HPGD 1810/4885
US-20080108846-A1 PROCESS FOR PRODUCING ALKOXYCARBONYLFLUOROALKANESULFONATES ARSA, PFAS, MPST MAPT 4791/4885RAB9A 1361/4885HPGD 3522/4885
US-20100035185-A1 Compound for Photoacid Generator, Resist Composition Using the Same, and Pattern-Forming Method ASIC1, RER1, INSRR MAPT 4347/4885RAB9A 686/4885HPGD 3082/4885
US-20130130175-A1 Compound for Photoacid Generator, Resist Composition Using the Same, and Pattern-Forming Method ASIC1, RER1, INSRR MAPT 4438/4885RAB9A 597/4885HPGD 3236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.